Orthotics and exercise outperform medication: simple therapies offer greater relief for knee osteoarthritis with fewer risks.

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

Home > Press release: Knee joint osteoarthritis replicated in ... Frankfurt UAS develops in vitro model for investigating early stages of the disease ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

"Cartilage, it doesn't heal on its own. So this is a way to help the body heal and reform cartilage," Gomoll said.

Osteoarthritis of the knee is not solved by a bottle of medicine, and rarely on an operating table. The most effective ...

On August 18, 2025, Enlivex announced the 3-month topline data, reporting that Allocetra™ demonstrated, in the primary age group (60+), substantial reduction in pain and improvement in function across ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Doctors warn that youngsters are wrecking their knee joints with silly acrobatics and daredevil dance moves for 10-seconds ...